Peptides

“My next frontier that I'm really getting involved in is, like, longevity, ok? Peptides, stem cells, all of that. Like, I think that is the wave of the future. Like, I think that is gonna change the scope of people's lives.”

“I don't think they can be covered by insurance anytime soon. So like that really cuts the market way, way, way down. Like if you don't have payers involved, like GLP ones, it's much harder to make huge businesses out of it.”

“Pipeline used to be largely small molecules. It's now shifting to large molecules in biologics and peptides, and also another class of compounds called oligonucleotides.”

“You won't see us be first to market in this category. You'll see us when we launch it, feel extremely confident in the clinical protocols, extremely confident in the guardrails, make sure that the supply chain and the quality is done to a level we are, you kno…”

“I'm very concerned about the peptide craze. I think it comes mostly out of psychological issues which we'll discuss. The need for identity, control distrust of institutions, all kinds of things like that are leading to what we're seeing today.”

“I also think as a modality, peptides are one that are more interesting than before, now that injecting is normal. Now the wellness and optimization is normal, not just treating disease, and now that we have AI for things like computational discovery.”

“And in fact, in pharma, you try to avoid peptides because of their inherent weaknesses. You go for small molecules or Really large molecules like antibodies. Peptides are sort of the worst of both worlds.”

“And we've seen one category of peptides GLP-ONE's already changed the world, and my contention is that there are other categories of peptides that are under-researched, but have really interesting kind of clinical vignettes that might change the world going fo…”

“The people that are take peptides and have these peptide stacks are mostly people in SF, maybe New York. They're very wealthy people. They don't know what the rest of the world looks like. Nobody else in middle, middle America is excited to do this.”

“I do not think anyone should inject peptides that are labeled as for research purposes only because even if it says 99% purity, the one percent is likely to be something called LPS, lipopolysaccharide, which can cause inflammation. It's not a good thing to be …”

“Some peptides have done the clinical work, like there's hepatitis, but then there's a whole bunch of the class of peptides that we have no human data on.”

“There's a general pattern. I think in a, in trying to design things that are smaller, you know, like it's easier to manufacture. At the same time, like that comes with like potentially other challenges, like maybe a little bit less selectivity than like, if yo…”

“Oh man, I think peptides are going to be so disruptive to our current healthcare system. You know, I think that if you look at peptides there needs to be way more research. I'm like, not totally yet a peptide believer. But there needs to be way more research, …”

“It's my opinion that every single peptide, not just GLP-I, every single peptide shouldn't be getting tested in the gray market of, like, gyms and, like, biohacking. That's, frankly, that's bullshit.”

“Even with my best intentions at 50 years old, my metabolic health was starting to become compromised because of chronic stress. There's not, you know, there's not much I can do outside. I'm doing the gym. I'm doing the food. I'm doing all the things. And I was…”

“Peptides don't grow much muscle. They do help with some kind of joint healing properties. They have fat loss properties.”